Alnylam Pharmaceuticals Faces Sharp Market Reversal as Amvuttra Sales Miss and Guidance Cut Trigger 30% Stock Plunge
admin Cambridge, MA – Alnylam Pharmaceuticals, a pioneering force in RNA interference (RNAi) therapeutics, experienced a...
biotech
Paving the Path to a Cancer-Free Future: The Enduring Impact of Legacy Gifts to the Cancer Research Institute
Including the Cancer Research Institute (CRI) in your will represents a profoundly personal and impactful...
FDA Advisory Panel Recommends Replimune’s RP1 for Advanced Melanoma, Overriding Agency Scientist Concerns and Paving Way for Crucial Approval
In a pivotal decision that could redefine treatment pathways for a challenging subset of melanoma...
Safeguarding Your Skin: Unpacking UV Radiation Risks, Prevention, and the Immunotherapy Revolution Against Skin Cancer
July marks Ultraviolet (UV) Radiation Safety Awareness Month, an annual observance underscoring the critical importance...
Hims & Hers Faces Federal Scrutiny Over Allegations of Health Data Sharing and Deceptive Subscription Practices
A federal lawsuit filed in California has cast a significant shadow over Hims & Hers,...
Sarcoma Awareness Month: Unpacking the Complexities and Emerging Hope of Immunotherapy
Sarcoma, a rare and notably complex group of cancers, has historically presented significant therapeutic challenges,...
Vertex Pharmaceuticals Partners with AbCellera to Advance T-Cell Engagers for Autoimmune Diseases, Bolstering Diversification Efforts
Vertex Pharmaceuticals, a biopharmaceutical giant predominantly known for its transformative cystic fibrosis treatments, has officially...
MapLight Therapeutics’ Schizophrenia Drug Navigates Investor Skepticism Amidst Promising Clinical Data and Broader Therapeutic Potential
Despite announcing positive results from a pivotal Phase 2b study for its experimental schizophrenia medicine...
FDA Advisory Committee Delivers Blow to Capricor’s Duchenne Therapy Amidst Contentious Regulatory Review and Statistical Discrepancies
In a closely watched decision that underscores the complex and often contentious landscape of rare...
Caldera, Vidya add to recent flurry of biotech mergers
The dynamic landscape of biotechnology witnessed a significant strategic shift this week as two burgeoning...
